CalciMedica, Inc. (CALC) Key Statistics & Financial Ratios

CalciMedica, Inc. (CALC) — Price $1.98 — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Key statistics dashboard for CalciMedica, Inc. (CALC). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions.

Stock Data

Price$1.98
Market Cap$6M
Enterprise Value-$12.4M
Beta1.09
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-0.29
Price / Book1.23
P/S0.00
EV/EBITDA0.62
EV/Sales0.00
EV/FCF0.65
P/FCF-0.33
Earnings Yield-313.65%
FCF Yield-306.68%
Dividend Yield0.00%

Profitability

Gross Margin0.00%
EBIT Margin0.00%
EBITDA Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity3398.40%
Return on Assets-108.91%
Return on Invested Capital-122.56%
Return on Capital Employed-122.56%

Financial Health

Current Ratio5.58
Quick Ratio5.58
Cash Ratio5.33
Debt / Equity0.00
Debt / Assets0.00%
Net Debt / EBITDA0.93
Interest Coverage-15.16

Per-Share Data

Revenue per share0.00
Book Value per share1.61
Cash per share5.44
FCF per share-5.59
Tangible Book Value per share1.61
Dividend per share0.00

Related companies: ATNM · ELUT · LTRN · LVTX · MAIA · PDSB · RNXT

Explore sector: Healthcare · Biotechnology

More sections of CALC: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks